BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2006
View Archived Issues
Combination of raf antisense oligonucleotide and radiation feasible in cancer patients
Read More
Preclinical studies reveal tolerability of ICA-17043
Read More
No developmental toxicity seen with CJC-1295 in rats
Read More
Gene silencing of ApoB in primates sees research collaboration between Inex and Alnylam
Read More
SCA-136: a 5-HT2C agonist in phase II study for schizophrenia
Read More
Potent hypolipidemic effects of new selective PPARalpha agonists
Read More
Lacosamide shows efficacy in treating epilepsy
Read More
Japanese phase I study cleared to begin for OTS-102
Read More
Novartis exercises option to inlicense valopicitabine
Read More
Abgenix stockholders approve acquisition by Amgen
Read More
Enrollment suspended in TROICA study of Metalyse
Read More
First IRB approval for phase III study of defibrotide in severe venoocclusive disease
Read More
SP-1000 shown to reduce blood cholesterol in animal studies
Read More
Adherex amends phase II study of ADH-1
Read More
Enrollment open in study of Amplimexon in multiple myeloma
Read More
Phase III trials set to begin for OPT-99 in bacterial gastroenteritis
Read More
Karo Bio profiles pipeline developments
Read More
Novartis and Servier sign licensing agreement for agomelatine
Read More
APD-356 on track to begin phase III obesity studies in H2 2006
Read More
FDA requests further data prior to phase II studies of APD-125 in chronic insomnia
Read More
Lilly presents preclinical data on novel oral mineralocorticoid receptor antagonists at ACS meeting
Read More
New phase I study evaluates PXD-101 with bortezomib for advanced malignancies
Read More
PowderMed's DNA vaccine for hepatitis B enters phase I trials
Read More
NVP-AEB-071: A novel PKC inhibitor to prevent graft rejection
Read More
Pharmion seeks approval for intravenous administration of Vidaza
Read More
European approval for quarterly Bonviva injection
Read More
New selective T-type calcium channel blockers discovered
Read More
Novel melanin-concentrating hormone receptor-1 antagonists for the treatment of obesity described
Read More
Recent patents describe novel therapeutics for cardiovascular disorders
Read More
Recent AstraZeneca and Actelion patents impart new therapeutics for respiratory disorders
Read More
Novel therapeutic agents imparted for inflammatory disorders
Read More